Summit Biotech Fund backs opportunities in the ASX healthcare space and sees upside in three particular names including ...

A bolstered clinical development team will help Tryptamine progress lead drug candidate IV-infused psilocin TRP-8803, including a world-first trial. Appointments come ahead of world-first clinical ...

Tryptamine Therapeutics has kicked off patient recruitment for its world-first psilocin trial targeting Binge Eating Disorder ...

Tryptamine has kicked off its world-first Binge Eating Disorder trial with psilocin, with dosing around the corner and potential to crack a big market. It’s a major step for Tryptamine ...

Special Report: Tryptamine Therapeutics has kicked off patient recruitment for its world-first psilocin trial targeting Binge Eating Disorder (BED), with dosing set to start this quarter and a ...

Tryptamine has kicked off its world-first Binge Eating Disorder trial with psilocin, with dosing around the corner and potential to crack a big market. It’s a major step for Tryptamine ...

Tryptamine has kicked off its world-first Binge Eating Disorder trial with psilocin, with dosing around the corner and potential to crack a big market. It’s a major step for Tryptamine ...

Eating disorders are among the deadliest psychological disorders, but there are no approved medical interventions for them – yet.

The Stanley Brothers created Charlotte's Web, the CBD supplement that’s worked wonders on seizures. Now they are developing pharmaceuticals derived from cannabis and psilocybin with hopes of ...

A broad spectrum anti-viral, Galidesivir is claimed to be effective against more than 20 viruses, including the hideous ...

There is no assurance that the use of psilocin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds can diagnose, treat, cure or prevent any disease or condition.